Haemonetics CorpNYSE:HAE
- LAST PRICE87.4700
- TODAY'S CHANGE (%)-0.4200 (-0.4779%)
- Bid / Lots84.3300/ 1
- Ask / Lots89.0000/ 1
- Open / Previous Close87.9200 / 87.8900
- Day Range
- 52 Week Range
- Volume273,618
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HAE |
|---|---|---|
| 09:32 ET | 3936 | 87.92 |
| 09:35 ET | 100 | 88.125 |
| 09:44 ET | 476 | 88.065 |
| 09:46 ET | 666 | 88.3544 |
| 09:48 ET | 100 | 88.07 |
| 09:51 ET | 500 | 88.075 |
| 10:02 ET | 3300 | 88.05 |
| 10:06 ET | 303 | 87.85 |
| 10:08 ET | 200 | 88.07 |
| 10:09 ET | 400 | 88.315 |
| 10:13 ET | 400 | 88.54 |
| 10:18 ET | 614 | 88.35 |
| 10:20 ET | 500 | 88.35 |
| 10:22 ET | 200 | 88.355 |
| 10:24 ET | 100 | 88.36 |
| 10:26 ET | 1900 | 88.335 |
| 10:31 ET | 500 | 88.27 |
| 10:33 ET | 300 | 88.02 |
| 10:38 ET | 835 | 87.95 |
| 10:40 ET | 500 | 88.01 |
| 10:42 ET | 100 | 87.93 |
| 10:44 ET | 100 | 87.95 |
| 10:45 ET | 3619 | 88.275 |
| 10:47 ET | 2307 | 88.46 |
| 10:49 ET | 400 | 88.72 |
| 10:51 ET | 100 | 88.86 |
| 10:56 ET | 200 | 88.66 |
| 10:58 ET | 300 | 88.345 |
| 11:00 ET | 200 | 88.375 |
| 11:02 ET | 400 | 88.16 |
| 11:07 ET | 100 | 88.08 |
| 11:14 ET | 576 | 87.935 |
| 11:18 ET | 900 | 88.03 |
| 11:20 ET | 300 | 88.095 |
| 11:23 ET | 400 | 88.05 |
| 11:25 ET | 398 | 88.1 |
| 11:27 ET | 300 | 88.1 |
| 11:30 ET | 400 | 88.08 |
| 11:32 ET | 1600 | 88.09 |
| 11:34 ET | 100 | 88.1 |
| 11:36 ET | 300 | 88.105 |
| 11:38 ET | 200 | 88.1 |
| 11:39 ET | 108 | 88.1 |
| 11:41 ET | 1100 | 87.96 |
| 11:43 ET | 300 | 87.81 |
| 11:45 ET | 100 | 87.895 |
| 11:52 ET | 100 | 87.8 |
| 11:54 ET | 800 | 87.56 |
| 11:56 ET | 1300 | 87.8 |
| 11:59 ET | 500 | 87.705 |
| 12:01 ET | 200 | 87.8 |
| 12:06 ET | 100 | 87.795 |
| 12:14 ET | 512 | 87.79 |
| 12:15 ET | 505 | 87.84 |
| 12:17 ET | 1008 | 87.59 |
| 12:19 ET | 403 | 87.665 |
| 12:21 ET | 400 | 87.74 |
| 12:24 ET | 100 | 87.82 |
| 12:26 ET | 100 | 87.765 |
| 12:28 ET | 315 | 87.71 |
| 12:30 ET | 800 | 87.78 |
| 12:32 ET | 1116 | 87.825 |
| 12:33 ET | 100 | 87.835 |
| 12:35 ET | 200 | 87.84 |
| 12:37 ET | 1278 | 87.795 |
| 12:39 ET | 500 | 87.9 |
| 12:44 ET | 798 | 87.98 |
| 12:46 ET | 1000 | 88.09 |
| 12:48 ET | 300 | 88.09 |
| 12:50 ET | 1497 | 88.04 |
| 12:51 ET | 3914 | 87.74 |
| 12:53 ET | 2090 | 87.71 |
| 12:55 ET | 3617 | 87.71 |
| 12:57 ET | 9300 | 87.41 |
| 01:00 ET | 115852 | 87.47 |
Nov 15, 2024
DJ Haemonetics Price Target Maintained With a $112.00/Share by Needham, from 2:30PM ET on Friday Nov 15, 2024 by Dow Jones
2:30PM ET on Friday Nov 15, 2024 by Dow Jones
Nov 8, 2024
DJ Haemonetics Is Maintained at Outperform by Barrington Research, from 4:22PM ET on Friday Nov 08, 2024 by Dow Jones
4:22PM ET on Friday Nov 08, 2024 by Dow JonesDJ Haemonetics Raised to Strong Buy From Outperform by Raymond James, from 7:04AM ET on Friday Nov 08, 2024 by Dow Jones
7:04AM ET on Friday Nov 08, 2024 by Dow Jones
Nov 7, 2024
Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website, from 6:00AM ET on Thursday Nov 07, 2024 by Dow Jones
6:00AM ET on Thursday Nov 07, 2024 by Dow JonesPress Release: Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website, from 6:00AM ET on Thursday Nov 07, 2024 by Dow Jones
6:00AM ET on Thursday Nov 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Haemonetics Corp | 4.4B | 36.3x | +17.09% |
Guardant Health Inc | 4.2B | -8.4x | --- |
ICU Medical Inc | 3.9B | -35.9x | --- |
Merit Medical Systems Inc | 6.1B | 50.9x | +14.05% |
Neogen Corp | 3.1B | -130.5x | --- |
Envista Holdings Corp | 3.8B | -2.9x | --- |
Company Information
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment includes blood collection and processing devices and disposables for red cells, platelets and whole blood. The Company’s Hospital segment consists of Interventional Technologies, which includes vascular closure devices and sensor-guided technologies, and Blood Management Technologies, which includes devices and methodologies for measuring coagulation characteristics of blood, and blood transfusion management software, among others.
Contact Information
- Headquarters
- 125 Summer StreetBOSTON, MA, United States 02110
- Phone
- 781-848-7100
- Fax
- ---
Executives
- Independent Chairman of the Board
- Ellen Zane
- President, Chief Executive Officer, Director
- Christopher Simon
- Executive Vice President, Chief Financial Officer
- James D'arecca
- President - Global Plasma and Blood Center
- Roy Galvin
- President - Global Hospital
- Stewart Strong
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.4B |
|---|---|
Revenue (TTM) | $1.4B |
Shares Outstanding | 50.2M |
Haemonetics Corp does not pay a dividend. | |
Beta | 0.38 |
EPS | $2.41 |
Book Value | $18.90 |
P/E Ratio | 36.3x |
Price/Sales (TTM) | 3.2 |
Price/Cash Flow (TTM) | 18.9x |
Operating Margin | 12.30% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
